Electroconvulsive therapy-induced persistent retrograde amnesia: Could it be minimised by ketamine or other pharmacological approaches?

Journal of Affective Disorders

Volumn 126, Issue 1-2, 2010, Pages 39-45

  Gregory Roberts, Emily M ^a   Naismith, Sharon L ^a   Cullen, Karen M ^a   Hickie, Ian B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Amnesia, retrograde; Electroconvulsive therapy; Excitatory amino acid antagonists; Ketamine; Receptors, N methyl D aspartate

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; AMLODIPINE; ANESTHETIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CAFFEINE; CYCLOOXYGENASE 2; DEXAMETHASONE; DIHYDROERGOTAMINE MESILATE; DONEPEZIL; FELODIPINE; GLUTAMATE RECEPTOR; INDOMETACIN; KETAMINE; LIOTHYRONINE; METHOHEXITAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NIMODIPINE; NITROPRUSSIDE SODIUM; NITROUS OXIDE; PIRACETAM; PROTIRELIN; THYROID HORMONE; VASOPRESSIN; VERAPAMIL; XENON;

ANESTHESIA; CLINICAL TRIAL; DEPRESSION; DRUG MEGADOSE; ELECTRIC SHOCK; ELECTROCONVULSIVE THERAPY; EPISODIC MEMORY; FOLLOW UP; HALLUCINATION; HUMAN; ILLUSION; LONG TERM POTENTIATION; MAJOR DEPRESSION; MEMORY DISORDER; MESH HEADING; MOSSY FIBER; PREDICTION; PRIORITY JOURNAL; RETROGRADE AMNESIA; REVIEW; SEIZURE; SEMANTIC MEMORY; SHORT TERM MEMORY; SYNAPSE; TEMPORAL LOBE; TREATMENT OUTCOME; TREATMENT RESPONSE;

AMNESIA, RETROGRADE; ANESTHETICS, DISSOCIATIVE; ELECTROCONVULSIVE THERAPY; HUMANS; KETAMINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 77956267259     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.11.018     Document Type: Review

References (100)

1. J.H. Abraini, H.N. David, and M. Lemaire Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon Ann. N. Y. Acad. Sci. 1053 2005 289 300
2. American Psychiatric Association Practice Guideline for Major Depressive Disorder in Adults 1993 American Psychiatric Association Washington, DC
3. C. Andrade Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: a decade of research Indian J. Psychiatry 50 2008 244 252
4. C. Andrade, N.M. Singh, S. Thyagarajan, N. Nagaraja, N. Sanjay Kumar Rao, and J. Suresh Chandra Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature J. Psychiatr. Res. 42 2008 837 850
5. C. Andrade, S. Thyagarajan, N.M. Singh, P.S. Vinod, N. Sanjay Kumar Rao, and J.S. Chandra Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT J. Neural. Transm. 115 2008 1063 1070
6. APA Committee on Electroconvulsive Therapy The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging 2001 American Psychiatric Association Washington, DC
7. A.D. Baddeley, B.A. Wilson, and F.N. Watts Handbook of Memory Disorders 1995 Wiley & Sons Chichester
8. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, and J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol. Psychiatry 47 2000 351 354
9. C.L. Brewer, J.R. Davidson, and S. Hereward Ketamine ("Ketalar" ): a safer anaesthetic for ECT Br. J. Psychiatry 120 1972 679 680
10. V.H. Brun, K. Ytterbo, R.G. Morris, M.B. Moser, and E.I. Moser Retrograde amnesia for spatial memory induced by NMDA receptor-mediated long-term potentiation J. Neurosci. 21 2001 356 362
11. A. Calev, D. Nigal, B. Shapira, N. Tubi, S. Chazan, Y. Ben-Yehuda, S. Kugelmass, and B. Lerer Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions J. Nerv. Ment. Dis. 179 1991 526 533
12. E. Chamberlin, and G.E. Tsai A glutamatergic model of ECT-induced memory dysfunction Harv. Rev. Psychiatry 5 1998 307 317
13. A.C. Chen, K.H. Shin, R.S. Duman, and G. Sanacora ECS-induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment J. ECT 17 2001 27 32
14. C.E. Coffey, G.S. Figiel, R.D. Weiner, and W.B. Saunders Caffeine augmentation of ECT Am. J. Psychiatry 147 1990 579 585
15. C.E. Coffey, R.D. Weiner, W.T. Djang, G.S. Figiel, S.A. Soady, L.J. Patterson, P.D. Holt, C.E. Spritzer, and W.E. Wilkinson Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study Arch. Gen. Psychiatry 48 1991 1013 1021
16. M.R. Cohen, and C.M. Swartz Absence of nimodipine premedication effect on memory after electroconvulsive therapy Neuropsychobiology 24 1990 165 168
17. D.P. Devanand, A.J. Dwork, E.R. Hutchinson, T.G. Bolwig, and H.A. Sackeim Does ECT alter brain structure? Am. J. Psychiatry 151 1994 957 970
18. P. Dillon, J. Copeland, and K. Jansen Patterns of use and harms associated with non-medical ketamine use Drug Alcohol Depend. 69 2003 23 28
19. S.L. Dubovsky, R. Buzan, M. Thomas, C. Kassner, and C.M. Cullum Nicardipine improves the antidepressant action of ECT but does not improve cognition J. ECT 17 2001 3 10
20. R.S. Duman, G.R. Heninger, and E.J. Nestler A molecular and cellular theory of depression Arch. Gen. Psychiatry 54 1997 597 606
21. A.J. Dwork, V. Arango, M. Underwood, B. Ilievski, G. Rosoklija, H.A. Sackeim, and S.H. Lisanby Absence of histological lesions in primate models of ECT and magnetic seizure therapy Am. J. Psychiatry 161 2004 576 578
22. D.H. Ezzat, M.M. Ibraheem, and B. Makhawy The effect of piracetam on ECT-induced memory disturbances Br. J. Psychiatry 147 1985 720 721
23. N.B. Farber, S.H. Kim, K. Dikranian, X.P. Jiang, and C. Heinkel Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity Mol. Psychiatry 7 2002 32 43
24. M.R. Farlow NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease Geriatrics 59 2004 22 27
25. R. Ferrucci, M. Bortolomasi, M. Vergari, L. Tadini, B. Salvoro, M. Giacopuzzi, S. Barbieri, and A. Priori Transcranial direct current stimulation in severe, drug-resistant major depression J. Affect. Disord. 118 2009 215 219
26. H.W. Goforth, and T. Holsinger Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy J. ECT 23 2007 23 25
27. I. Hickie, B. Parsonage, and G. Parker Prediction of response to electroconvulsive therapy: preliminary validation of a sign-based typology of depression Br. J. Psychiatry 157 1990 65 71
28. I. Hickie, E. Scott, P. Mitchell, K. Wilhelm, M. Austin, and B. Bennett Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression Biol. Psychiatry 37 1995 151 160
29. I. Hickie, C. Mason, and G. Parker Comparative validity of two measures of psychomotor function in patients with severe depression J. Affect. Disord. 37 1996 143 149
30. I.B. Hickie, S.L. Naismith, P.B. Ward, C.L. Little, M. Pearson, E.M. Scott, P. Mitchell, K. Wilhelm, and G. Parker Psychomotor slowing in older patients with major depression: relationships with blood flow in the caudate nucleus and white matter lesions Psychiatry Res. 155 2007 211 220
31. S. Himmelseher, and E. Pfenninger The clinical use of S-(+)-ketamine-a determination of its place Anasthesio. Intensivmed. Notfmed. Schmerzther. 33 1998 764 770
32. R.L. Horne, H.M. Pettinati, M. Menken, A.A. Sugerman, E. Varga, and G.F. Wilson Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia Biol. Psychiatry 19 1984 13 27
33. S. Kamath, C. Andrade, S. Faruqi, B.V. Venkataraman, M.A. Naga Rani, and V.S. Candade Evaluation of pre-ECS antihypertensive drug administration in the attenuation of ECS-induced retrograde amnesia Convuls. Ther. 13 1997 185 195
34. F. Karege, G. Perret, G. Bondolfi, M. Schwald, G. Bertschy, and J.M. Aubry Decreased serum brain-derived neurotrophic factor levels in major depressed patients Psychiatry Res. 109 2002 143 148
35. S.P. Koffler, B.M. Hampstead, F. Irani, J. Tinker, R.T. Kiefer, P. Rohr, and R.J. Schwartzman The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome Arch. Clin. Neuropsychol. 22 2007 719 729
36. R. Kohrs, and M.E. Durieux Ketamine: teaching an old drug new tricks Anesth. Analg. 87 1998 1186 1193
37. A.D. Krystal, R.D. Weiner, M.D. Dean, V.H. Lindahl, L.A. Tramontozzi III, G. Falcone, and C.E. Coffey Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT J. Neuropsychiatr. Clin. Neurosci. 15 2003 27 34
38. A.C. Lahti, H.H. Holcomb, D.R. Medoff, and C.A. Tamminga Ketamine activates psychosis and alters limbic blood flow in schizophrenia NeuroReport 6 1995 869 872
39. S.R. Lamont, B.J. Stanwell, R. Hill, I.C. Reid, and C.A. Stewart Ketamine pre-treatment dissociates the effects of electroconvulsive stimulation on mossy fibre sprouting and cellular proliferation in the dentate gyrus Brain Res. 1053 2005 27 32
40. J. Levine, T. Pomerantz, S. Stier, and R.H. Belmaker Lack of effect of 6 g inositol treatment of post-ECT cognitive function in humans J. Psychiatr. Res. 29 1995 487 489
41. S.H. Lisanby Electroconvulsive therapy for depression N. Engl. J. Med. 357 2007 1939 1945
42. S.H. Lisanby, J.H. Maddox, J. Prudic, D.P. Devanand, and H.A. Sackeim The effects of electroconvulsive therapy on memory of autobiographical and public events Arch. Gen. Psychiatry 57 2000 581 590
43. R.J. Lunn, M.M. Savageau, W.W. Beatty, J.W. Gerst, R.D. Staton, and R.A. Brumback Anesthetics and electroconvulsive therapy seizure duration: implications for therapy from a rat model Biol. Psychiatry 16 1981 1163 1175
44. R. MacPherson, and C. Loo Cognitive impairment following electroconvulsive therapy-does the choice of anesthetic agent make a difference? J. ECT 24 2008 52 56
45. J.A. Mattes, H.M. Pettinati, S. Stephens, S.E. Robin, and K.W. Willis A placebo-controlled evaluation of vasopressin for ECT-induced memory impairment Biol. Psychiatry 27 1990 289 303
46. W.V. McCall Levels of evidence, causality, and clinical significance J. ECT 23 2007 69 70
47. W.V. McCall, A. Dunn, P.B. Rosenquist, and D. Hughes Markedly suprathreshold right unilateral ECT versus minimally suprathreshold bilateral ECT: antidepressant and memory effects J. ECT 18 2002 126 129
48. W.V. McCall, A. Dunn, and P.B. Rosenquist Quality of life and function after electroconvulsive therapy Br. J. Psychiatry 185 2004 405 409
49. W.V. McCall, J. Prudic, M. Olfson, and H. Sackeim Health-related quality of life following ECT in a large community sample J. Affect. Disord. 90 2006 269 274
50. W.W. McDaniel, A.K. Sahota, B.V. Vyas, N. Laguerta, L. Hategan, and J. Oswald Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies J. ECT 22 2006 103 106
51. M.C. McElhiney, B.J. Moody, B.L. Steif, J. Prudic, D.P. Devanand, M.S. Nobler, and H.A. Sackeim Autobiographical memory and mood: effects of electroconvulsive therapy Neuropsychology 9 1995 501 517
52. E.J. McInnes, and N.M. James A comparison of ketamine and methohexital in electroconvulsive therapy Med. J. Aust. 1 1972 1031 1032
53. P. Mitchell, T. Torda, I. Hickie, and C. Burke Propofol as an anaesthetic agent for ECT: effect on outcome and length of course Aust. NZ J. Psychiatry 25 1991 255 261
54. C.J. Morgan, and H.V. Curran Acute and chronic effects of ketamine upon human memory: a review Psychopharmacology (Berl.) 188 2006 408 424
55. C.J.A. Morgan, L. Monaghan, and H.V. Curran Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug Addiction 99 2004 1450 1461
56. N. Nagaraja, C. Andrade, S. Sudha, N.M. Singh, J.S. Chandra, and B.V. Venkataraman Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia Psychopharmacology (Berl.) 190 2007 73 80
57. S.L. Naismith, W.A. Longley, E.M. Scott, and I.B. Hickie Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study BMC Psychiatry 7 2007 32
58. S.S. Newton, E.F. Collier, J. Hunsberger, D. Adams, R. Terwilliger, E. Selvanayagam, and R.S. Duman Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors J. Neurosci. 23 2003 10841 10851
59. C. Ng, I. Schweitzer, P. Alexopoulos, E. Celi, L. Wong, V. Tuckwell, A. Sergejew, and J. Tiller Efficacy and cognitive effects of right unilateral electroconvulsive therapy J. ECT 16 2000 370 379
60. M.S. Nobler, and H.A. Sackeim Neurobiological correlates of the cognitive side effects of electroconvulsive therapy J. ECT 24 2008 40 45
61. R. Ostroff, M. Gonzales, and G. Sanacora Antidepressant effect of ketamine during ECT Am. J. Psychiatry 162 2005 1385 1386
62. D. Pagnin, V. de Queiroz, S. Pini, and G.B. Cassano Efficacy of ECT in depression: a meta-analytic review J. ECT 20 2004 13 20
63. I.A. Paul, and P. Skolnick Glutamate and depression: clinical and preclinical studies Ann. N. Y. Acad. Sci. 1003 2003 250 272
64. M. Pedler Shock Treatment: A Survey of People's Experiences of Electro-Convulsive Therapy (ECT) 2001 MIND London
65. R.X. Petrie, I.C. Reid, and C.A. Stewart The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review Pharmacol. Ther. 87 2000 11 25
66. E.G. Pfenninger, M.E. Durieux, and S. Himmelseher Cognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers Anesthesiology 96 2002 357 366
67. M. Pigot, C. Andrade, and C. Loo Pharmacological attenuation of electroconvulsive therapy-induced cognitive deficits: theoretical background and clinical findings J. ECT 24 2008 57 67
68. C. Pittenger, and R.S. Duman Stress, depression, and neuroplasticity: a convergence of mechanisms Neuropsychopharmacology 33 2008 88 109
69. R. Porter, H. Heenan, and J. Reeves Early effects of electroconvulsive therapy on cognitive function J. ECT 24 2008 35 39
70. J. Prakash, A. Kotwal, and H. Prabhu Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial J. ECT 22 2006 163 168
71. J. Prudic, and H.A. Sackeim Electroconvulsive therapy and suicide risk J. Clin. Psychiatry 60 Suppl 2 1999 104 110
72. J. Prudic, L. Fitzsimons, M.S. Nobler, and H.A. Sackeim Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study Neuropsychopharmacology 21 1999 285 293
73. S.K. Rao, C. Andrade, K. Reddy, K.N. Madappa, S. Thyagarajan, and S. Chandra Memory protective effect of indomethacin against electroconvulsive shock-induced retrograde amnesia in rats Biol. Psychiatry 51 2002 770 773
74. K.G. Rasmussen, M.R. Jarvis, and C.F. Zorumski Ketamine anesthesia in electroconvulsive therapy Convuls. Ther. 12 1996 217 223
75. I.C. Reid, and C.A. Stewart Seizures, memory and synaptic plasticity Seizure 6 1997 351 359
76. D. Rose, P. Fleischmann, T. Wykes, M. Leese, and J. Bindman Patients' perspectives on electroconvulsive therapy: systematic review BMJ 326 2003 1363
77. G.S. Sachs, A.J. Gelenberg, B. Bellinghausen, J. Wojcik, W.E. Falk, A.M. Farhadi, and M. Jenike Ergoloid mesylates and ECT J. Clin. Psychiatry 50 1989 87 90
78. H.A. Sackeim Memory and ECT: from polarization to reconciliation J. ECT 16 2000 87 96
79. H.A. Sackeim, J. Prudic, D.P. Devanand, J.E. Kiersky, L. Fitzsimons, B.J. Moody, M.C. McElhiney, E.A. Coleman, and J.M. Settembrino Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy N. Engl. J. Med. 328 1993 839 846
80. H.A. Sackeim, B. Luber, J.R. Moeller, J. Prudic, D.P. Devanand, and M.S. Nobler Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy J. ECT 16 2000 110 120
81. H.A. Sackeim, J. Prudic, D.P. Devanand, M.S. Nobler, S.H. Lisanby, S. Peyser, L. Fitzsimons, B.J. Moody, and J. Clark A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities Arch. Gen. Psychiatry 57 2000 425 434
82. H.A. Sackeim, J. Prudic, R. Fuller, J. Keilp, P.W. Lavori, and M. Olfson The cognitive effects of electroconvulsive therapy in community settings Neuropsychopharmacology 32 2007 244 254
83. A.I.F. Scott, The ECT Handbook: The Third Report of the Royal College of Psychiatrists' Special Committee on ECT (Council Report CR128) 2005 Royal College of Psychiatrists London
84. C. Sobin, H.A. Sackeim, J. Prudic, D.P. Devanand, B.J. Moody, and M.C. McElhiney Predictors of retrograde amnesia following ECT Am. J. Psychiatry 152 1995 995 1001
85. L.R. Squire, P.C. Slater, and P.L. Miller Retrograde amnesia and bilateral electroconvulsive therapy. Long-term follow-up Arch. Gen. Psychiatry 38 1981 89 95
86. R.A. Stern, C.T. Nevels, M.E. Shelhorse, M.L. Prohaska, G.A. Mason, and A.J. Prange Jr. Antidepressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings Biol. Psychiatry 30 1991 623 627
87. C. Stewart, and I. Reid Electroconvulsive stimulation and synaptic plasticity in the rat Brain Res. 620 1993 139 141
88. C.A. Stewart, and I.C. Reid Ketamine prevents ECS-induced synaptic enhancement in rat hippocampus Neurosci. Lett. 178 1994 11 14
89. C. Stewart, K. Jeffery, and I. Reid LTP-like synaptic efficacy changes following electroconvulsive stimulation NeuroReport 5 1994 1041 1044
90. S. Sudha, C. Andrade, A. Anand, S. Guido, and B.V. Venkataraman Nitroprusside and ECS-induced retrograde amnesia J. ECT 17 2001 41 44
91. W.K. Tang, G.S. Ungvari, and H.C. Leung Effect of piracetam on ECT-induced cognitive disturbances: a randomized, placebo-controlled, double-blind study J. ECT 18 2002 130 137
92. J. Thomas, Australian Prescription Products Guide 1996 Australian Pharmaceutical Pub. Co. Hawthorn, Vic
93. G. Tremont, and R.A. Stern Use of thyroid hormone to diminish the cognitive side effects of psychiatric treatment Psychopharmacol. Bull. 33 1997 273 280
94. UK ECT Review Group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis Lancet 361 2003 799 808
95. M. Vamos The cognitive side effects of modern ECT: patient experience or objective measurement? J. ECT 24 2008 18 24
96. R.D. Weiner, H.J. Rogers, J.R. Davidson, and L.R. Squire Effects of stimulus parameters on cognitive side effects Ann. N. Y. Acad. Sci. 462 1986 315 325
97. T. Yamakura, and R.A. Harris Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol Anesthesiology 93 2000 1095 1101
98. C.A. Zarate Jr., J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, D.A. Luckenbaugh, D.S. Charney, and H.K. Manji A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch. Gen. Psychiatry 63 2006 856 864
99. I.M. Zervas, A.A. Pehlivanidis, Y.G. Papakostas, M. Markianos, G.N. Papadimitriou, and C.N. Stefanis Effects of TRH administration on orientation time and recall after ECT J. ECT 14 1998 236 240
100. G. Zupan, D. Vitezic, J. Mrsic, D. Matesic, and A. Simonic Effects of nimodipine, felodipine and amlodipine on electroconvulsive shock-induced amnesia in the rat Eur. J. Pharmacol. 310 1996 103 106